All eyes are on the election to determine the direction of the country's policies for the next two years. However, as investors our focus is primarily on how the election will affect the markets in which we live and make our livelihoods.
All indications and polls, which are as reliable as most stock pickers, lean towards a divided congress. The market historically likes gridlock, stability and no major shifts or changes. Regardless of the election outcomes, let's all aspire for better market conditions going into 2023 and beyond.
As anyone with a few gray hairs knows, the markets never stop regardless of the overall sentiment. At B2i Digital, we see continued interest from companies to engage with investors as our Featured Companies and to attend our Featured Conferences. Tomorrow we have the Sidoti November Micro-Cap Virtual Conference. Next week we will be in person at the Roth AgTech Conference and the Roth Technology Conference in New York City.
If you would like to join our family of Featured Companies to broaden your investor base, elevate awareness of your company story and open doors to more direct communications with investors, email david@b2idigital.com.
We look forward to seeing some of you in person next week at the Roth Conferences and we welcome you to get involved with the Sidoti event. See full details below.
(Nasdaq: BIOL) BIOLASE develops, manufactures, markets, and sells laser systems that provide significant benefits for dental practitioners and their patients. The Company's proprietary systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures.
(Nasdaq: AGRI) AgriFORCE is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world.
(Nasdaq: TIVC) Tivic Health Systems is a commercial-phase health technology company developing and commercializing bioelectronic medicine to improve health, treat certain conditions and diseases, and make a meaningful difference in people’s lives.
(Nasdaq: LUCY) Innovative Eyewear is the owner of the Lucyd brand of smart eyewear. Lucyd provides prescription smart frames direct-to-consumer and through retail distribution. Lucyd has 44 patents granted and pending and 11 trademarks, forming a growing IP position.
(Nasdaq: BRTX) BioRestorative isan emerging growth NASDAQ listed biopharma company focused on the research, development and commercialization of cellular therapies. They are currently clinical stage with two proprietary platform technologies focused on multi-billion dollar market opportunities. They are fully funded, after up listing on NASDAQ in 2021, and they transitioned to a pristine balance sheet, strong financial condition and believe they are well positioned to prosecute their clinical and corporate objectives.
(Nasdaq: UNCY) Unicycive is a biotechnology company dedicated to developing treatments for certain medical conditions. Currently, two of their programs are focused on kidney disease that they believe have the potential to offer medical benefit. Their current development programs are focused on two novel therapies: Renazorb, for treatment of hyperphosphatemia in patients with chronic kidney disease, and UNI 494, for treatment of acute kidney injury.
Nanōmix is a leader in decentralized testing and a participant in the large, fast-growing Point of Care (POC) diagnostics market. Their market-ready Critical Infection Panel is the only portable, rapid PCT assay and allows for obtaining critical information more quickly, leading to faster clinical decision-making.
Todos Medical Ltd. is an in vitro diagnostics company providing life-saving solutions, with a focus on the development of novel blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer’s Disease, as well as the distribution of comprehensive solutions for COVID-19 screening.
(NYSEAMERICAN: AIM)AIM ImmunoTech is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19.
(Nasdaq: AVCO) Avalon GloboCare is a clinical-stage biotechnology company dedicated to develop and deliver innovative and transformative CellTech with multifunctional convergence in cellular technologies & therapeutics, precision diagnostics and intellectual property in the field of immuno-oncology and cellular medicines.
(Nasdaq: SYTA) Siyata aims to be the global leader in the rapidly growing Push-to-Talk Over Cellular (PoC) industry by disrupting a legacy Industry with Next Generation Cellular Technology. This is an industry valued at $12.6 billion.
(Nasdaq: WISA) WiSA Technologies develops wireless audio integrated circuits for home entertainment and audio markets in the United States, Europe, and the Asia Pacific. WiSA believes that the future of audio technology is in wireless devices and that they are well positioned to deliver best-in-class immersive wireless sound technology.
(OTCQB: AMMX) AmeraMex International Inc. sells, rents, and leases new and refurbished heavy equipment to a wide variety of industries, including construction, mining, infrastructure, logging, logistics, transportation, forestry conservation and commercial farming.
(OTCQB: TGCB) Tego Cyber Inc. was created to capitalize on the emerging cyber threat intelligence market. They have developed a cyber threat intelligence application that integrates with leading security platforms to gather, analyze then identify threats to an enterprise network.
(Nasdaq: FWBI) First Wave BioPharma, Inc. is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
(OTCQB: BICX) BioCorRx® is a leading-edge healthcare solutions company focused on improving the lives of those struggling with alcoholism, opioid abuse, as well as other addictive disorders.
(Nasdaq: QNRX) Quoin Pharmaceuticals, Ltd. a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases.
We welcome your participation in the Sidoti November Micro-Cap conference and the back-to-back Roth conferences next week. It's going to be a busy 2 weeks and we look forward to facilitating engaging discussions between investors and management.
These conferences will provide investors the opportunity to meet with executive management from companies across a wide range of sectors. Visithttps://b2idigital.com/conferences to see all past and upcoming conferences.
Conferences are intended for qualified investors, companies, service providers and members of the media/press.
B2I DIGITAL, Inc. provides marketing support to the above mentioned conferences and their affiliated organizers ("Conferences"). B2I DIGITAL, Inc. is not an affiliate of the Conferences and is not authorized to represent or act on behalf of the Conferences, in any capacity. The Conferences have not reviewed and approved the content contained on the b2idigital.com website. Content about any specific company was provided and approved by that company. B2I DIGITAL, Inc. has not independently verified the accuracy of the information contained herein. No content contained herein shall be considered an offer to solicit the sale of any security.
I hope your favorite candidate wins and that the Bulls beat the Bears right out of this market!
